MTOR and Parkinson disease: Active PI3K/AKT signaling was manifested to evoke neuroprotection in PD via upregulating numerous downstream prosurvival substrates, including mTOR (Zheng et al. 2021a) and Nrf2 (Liu et al. 2021).